ImmunityBio
IBRX
#2434
Rank
NZ$12.79 B
Marketcap
NZ$12.39
Share price
-3.01%
Change (1 day)
152.46%
Change (1 year)

Market capitalization of ImmunityBio (IBRX)

Market cap: NZ$12.79 Billion

As of April 2026 ImmunityBio has a market cap of NZ$12.79 Billion. This makes ImmunityBio the world's 2434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunityBio from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$12.79 B251.63%
2025NZ$3.63 B1.12%
2024NZ$3.59 B-32.09%
2023NZ$5.30 B65.81%
2022NZ$3.19 B-9.72%
2021NZ$3.54 B

End of Day market cap according to different sources

On Apr 5th, 2026 the market cap of ImmunityBio was reported to be:

NZ$13.13 Billion
by Nasdaq info icon info icon
NZ$13.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.74 B-86.35%๐Ÿ‡บ๐Ÿ‡ธ USA